Navigation Links
Ambit Biosciences to Announce Third Quarter 2013 Financial and Operating Results and Conference Call
Date:11/1/2013

SAN DIEGO, Calif., Nov. 1, 2013 /PRNewswire/ -- Ambit Biosciences (Nasdaq: AMBI), a biopharmaceutical company focused on discovery and development of drugs targeting unmet needs in oncology, autoimmune and inflammatory disease, today announced that it will report third quarter 2013 operational results after closing of the NASDAQ Global Market on Thursday, November 7, 2013. Michael Martino, president and chief executive officer, will host a conference call to provide a business update at 5 p.m. EDT (2 p.m. PDT) on November 7, 2013.

The call will be webcast live and may be accessed by dialing 866-436-9172 for domestic callers and 630-691-2760 for international callers. Please specify that you would like to join the "Ambit Third Quarter 2013 Earnings Conference Call" and reference conference ID number 35424048.
A teleconference replay will be available through Thursday, November 14, 2013.  Interested parties can access the replay by dialing 888-843-7419, or 630-652-3042 internationally, and entering the conference number 35977176.

The conference call webcast is accessible through the "Investors & Media" section of the Ambit Biosciences website at http://www.ambitbio.com.  An online replay will be available following the initial broadcast until Saturday, December 7, 2013.  Please visit Ambit's website several minutes prior to the start of the broadcast to ensure adequate time for any software download that may be necessary.

About Ambit Biosciences
Ambit is a biopharmaceutical company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. Ambit's lead drug candidate, quizartin
'/>"/>

SOURCE Ambit Biosciences
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Ambit Biosciences Corporation Announces Second Quarter 2013 Operational Results
2. Ambit Biosciences to Announce Second Quarter 2013 Operational Results and Conference Call
3. Ambit Biosciences Announces Presentations of Data from Clinical Investigations of Quizartinib at the Annual Meeting of the American Society of Clinical Oncology
4. Lo studio pubblicato su European Radiology esalta ulteriormente lutilizzo della tomosintesi al seno di Hologic nellambito dello screening del cancro con utilizzo della doppia lettura
5. Ambit Biosciences Appoints David Parkinson, M.D., to Board of Directors
6. Astellas and Ambit to End Collaboration for Joint Development and Commercialization of FLT3 Kinase Inhibitors
7. Ambit and Astellas Announce Presentation of Results from Phase 2 ACE Study of Quizartinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia (AML) at the 54th Annual Meeting of the American Society of Hematology
8. Ambit Biosciences Completes $50 Million Financing to Advance Lead Drug Candidate in Acute Myeloid Leukemia
9. Ambit Biosciences and Teva Announce Clearance of an Investigational New Drug (IND) Application for CEP-32496, A Novel BRAF(V600E) Inhibitor
10. Calithera Biosciences Secures $35 Million in Series D Financing
11. Sangamo BioSciences Presents Clinical Data From HIV Study Demonstrating Sustained Control Of Viremia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... 2015 Celtaxsys, Inc., a clinical stage pharmaceutical ... rare and orphan inflammatory disease indications, announced today that ... Drug Administration (FDA) to begin a Phase 2 clinical ... adult CF patients in the US. The regulatory submissions ... will be filed soon after. This groundbreaking clinical ...
(Date:7/6/2015)... SOUTH SAN FRANCISCO, Calif. , July ... ), a leading global pharmaceutical company, and Oculeve, a ... for dry eye disease, today announced that they have ... Oculeve in an all-cash transaction.  Under the terms of ... million upfront payment and commercialization milestone payments related to ...
(Date:7/6/2015)... -- China Information Technology, Inc. (the "Company" or "CNIT") ... platform, exchange, and big data solutions in ... its mobile app for Healthcare One Pass, ushering in ... devices. The Company jointly hosted the launch ceremony with ... Shenzhen News Net.   The mobile app for ...
Breaking Medicine Technology:Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 2Celtaxsys, Inc. Gains FDA Clearance for Landmark Phase 2 Trial of Anti-Inflammatory Treatment for Cystic Fibrosis (CF) 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 2Allergan to Acquire Oculeve Dry Eye Disease Development Programs 3Allergan to Acquire Oculeve Dry Eye Disease Development Programs 4CNIT Launches the Mobile App for Healthcare One Pass 2CNIT Launches the Mobile App for Healthcare One Pass 3CNIT Launches the Mobile App for Healthcare One Pass 4
... ... Anticancer Drug, HOUSTON, ... to families, workplaces and communities, and many,Houstonians are aware of ... the CHRISTUS Stehlin Foundation for,Cancer Research, a nationally recognized leader ...
Journalists and other readers should disregard the news release "Oramed,Pharmaceuticals Launches Phase 1A Trials of its Insulin Suppository",OTC:ORMP, issued earlier today. The release was transmitted...
Cached Medicine Technology:Local Research Foundation Achieves Milestone in Fight Against Cancer 2Local Research Foundation Achieves Milestone in Fight Against Cancer 3
(Date:7/6/2015)... ... July 06, 2015 , ... Acara ... industries, announces the return of its complimentary educational webinar series for ... business leaders creates success for their clients through targeted marketing, sales, digital communications, ...
(Date:7/6/2015)... ... July 06, 2015 , ... The Asian-Pacific market for rheumatoid arthritis therapeutics ... to grow at a CAGR of over 3.2 percent in the years to come ... to be mainly spurred by an anticipated launch of a number of promising pipeline ...
(Date:7/6/2015)... ... ... doTERRA, the leading global essential oils company, is pleased to announce the ... position as Director of the Hinckley Institute at the University of Utah, a position ... states that he was ready for a new challenge, and out of many potential ...
(Date:7/6/2015)... ... 2015 , ... Seedstock today announced Pierre Sleiman, founder and CEO of ... Sustainable Agriculture Conference – “Innovation and the Small Farmer” – to be held Nov. ... California-San Diego, will explore solutions and methodologies that small farmers and entrepreneurs are developing ...
(Date:7/6/2015)... (PRWEB) , ... July 06, 2015 , ... MD Now, ... Monday, July 6. The newly constructed urgent care center will serve residents and visitors ... In addition to being MD Now’s 22nd South Florida location, the new facility will ...
Breaking Medicine News(10 mins):Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3Health News:APAC Rheumatoid Arthritis Therapeutics Market to Reach Value of USD 6.9 Billion by 2021, Says GBI Research in Its New Report Now Available at MarketPublishers.com 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 2Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 3Health News:doTERRA Welcomes Kirk Jowers to Its Executive Team 4Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 2Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 3Health News:Seedstock Names Go Green Agriculture Founder and CEO as 2015 Sustainable Agriculture Conference Keynote Speaker 4Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 2Health News:MD Now Urgent Care Opens its Fourth Miami-Dade County Facility in Cutler Bay 3
... ... ... ... ...
... ... ... ... ...
... ... the communications between devices, assets, equipment, vehicles etc. This free white ... and up-front costs. It describes how a cloud-based Platform as a ... deploy these applications. The paper describes how building and deploying these ...
... ... abuse , ... York, NY (PRWEB) February 23, 2010 -- The National Center on Elder Abuse ... injured, emotionally abused or financially exploited by a caregiver. These instances are not limited to ...
... ... address the Phoenix Thunderbird Chapter of the National Contract Management Association (NCMA) at their meeting ... use in fighting fraud against the Government. , ... Phoenix, AZ (PRWEB) February 23, 2010 -- Qui Tam Attorney Tim Terry ...
... ... ... ... ...
Cached Medicine News:Health News:Christiana Care Health System Achieves Magnet(R) Recognition 2Health News:Christiana Care Health System Achieves Magnet(R) Recognition 3Health News:Christiana Care Health System Achieves Magnet(R) Recognition 4Health News:BUAV Exposes Shocking Role Played by Laos in the International Trade in Primates for Research 2Health News:BUAV Exposes Shocking Role Played by Laos in the International Trade in Primates for Research 3Health News:BUAV Exposes Shocking Role Played by Laos in the International Trade in Primates for Research 4Health News:BUAV Exposes Shocking Role Played by Laos in the International Trade in Primates for Research 5Health News:Cloud Computing Platforms Address Unique M2M Application Needs, According To New SensorLogic White Paper 2Health News:Even at Home; Security is a Growing Concern for the Elderly 2Health News:Qui Tam Attorney Tim Terry to Speak at Phoenix Thunderbird Chapter of the National Contract Management Association (NCMA) 2Health News:Pew Report: Louisiana Failing to Address Children's Dental Health Crisis 2Health News:Pew Report: Louisiana Failing to Address Children's Dental Health Crisis 3Health News:Pew Report: Louisiana Failing to Address Children's Dental Health Crisis 4Health News:Pew Report: Louisiana Failing to Address Children's Dental Health Crisis 5Health News:Pew Report: Louisiana Failing to Address Children's Dental Health Crisis 6Health News:Pew Report: Louisiana Failing to Address Children's Dental Health Crisis 7
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: